DRX-Evolution with CSH WS These products are permanently installed diagnostic x-ray systems co...

FDA Device Recall #Z-0797-2014 — Class II — November 25, 2013

Recall Summary

Recall Number Z-0797-2014
Classification Class II — Moderate risk
Date Initiated November 25, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Carestream Health, Inc.
Location Rochester, NY
Product Type Devices
Quantity 840 units Total (181 units domestically & 659 units internationally)

Product Description

DRX-Evolution with CSH WS These products are permanently installed diagnostic x-ray systems composed of 4 main components: an operator console, over head tube crane, x-ray tube assembly including a collimator and stationary generator. In addition the device can use an x-ray table and /or wallstand/bucky to complete x-ray exposures. The DRX-Evolution system is a permanently installed diagnostic x-ray system for generation of x-rays for examination of various anatomical regions.

Reason for Recall

Carestream Health Inc. has issued a recall for the Carestream DRX-Evolution (FF WS and CSJ WS) and the Kodak DirectView DR 7500 System due to the potential for unexpected device movement.

Distribution Pattern

Worldwide Distribution: US (nationwide) including states of: CA, CO, FL, GA, IL,IN, MD, MI, MN, NC, ND, NJ, NY, OH, OK, PA, SC, SD, TN, TX, VA, WA, and WI; and internationally to: Australia Belgium, Canada, China, Finland, France, Germany, Hong Kong, Italy, Netherlands, New Zealand, Poland, Portugal, Spain, Sweden, Switzerland, Taiwan, Turkey, United Arab Emirates, and United Kingdom.

Lot / Code Information

Catalog Numbers: 1731678, 1731660, 1010990, 1030451, 1016138, 1030477, 1010982, 1030485; Service Code: 7171

Other Recalls from Carestream Health, Inc.

Recall # Classification Product Date
Z-0437-2024 Class II DRX Revolution Mobile X-Ray System Oct 2, 2023
Z-0289-2024 Class II The DRX-Revolution Mobile X-Ray System is a dia... Oct 2, 2023
Z-1206-2023 Class II DRX-Compass/DR-FIT X-ray Systems with Firmware ... Jan 30, 2023
Z-0806-2020 Class II Kodak DirectView DR3000/3500 - Product Usage: p... Jan 6, 2020
Z-1207-2019 Class II OnSight 3D Extremity System- X-Ray, Tomography ... Mar 19, 2019

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.